Levosalbutamol Inhaler – Product Introduction
Levosalbutamol (Levalbuterol) Inhaler is a short-acting beta-2 adrenergic bronchodilator used for the treatment or prevention of bronchospasm associated with reversible obstructive airway conditions. It works by relaxing airway smooth muscle and helping improve airflow.
Cordium Pharmaceuticals Pvt Ltd supports B2B pharmaceutical supply and international export enquiries for respiratory medicines, subject to destination-country regulatory requirements and applicable approvals.
Product Specification
Specification
Details
Product Name
Levosalbutamol Inhaler
Generic Name
Levosalbutamol / Levalbuterol
Therapeutic Category
Bronchodilator
Pharmacological Class
Short-acting β2-adrenergic agonist
Dosage Form
Metered-dose inhalation aerosol
Route
Oral inhalation
Main Use
Treatment/prevention of bronchospasm
Target Buyers
Hospitals, Clinics, Pharmacies, Distributors & Importers
Supply Type
B2B / Pharmaceutical Export
Prescription Status
Subject to destination-country regulations
Important: Exact strength, actuation content, pack size and registration status should be confirmed against the specific product presentation and destination market before commercial supply.
Uses of Levosalbutamol Inhaler
Levosalbutamol inhalation products are used for:
Relief/prevention of bronchospasm
Reversible obstructive airway disease
Asthma-related bronchospasm
Bronchodilation under medical supervision
The U.S. prescribing information for levalbuterol inhalation aerosol indicates use for treatment or prevention of bronchospasm in adults, adolescents and children aged 4 years and older with reversible obstructive airway disease.
Mechanism of Action
Levosalbutamol is a selective β2-adrenergic receptor agonist. It stimulates β2 receptors in bronchial smooth muscle, activating intracellular pathways that promote smooth-muscle relaxation. This produces bronchodilation and improved airflow.
Dosage Information
Dosage depends on the specific inhaler strength, age, clinical condition and prescribing information applicable in the destination country.
For the U.S.-labelled levalbuterol HFA inhaler, the recommended dosage for adults and children aged 4 years and older is generally 2 inhalations (90 mcg levalbuterol free base) every 4–6 hours; for some patients, 1 inhalation every 4 hours may be sufficient. More frequent administration or higher doses are not routinely recommended.
Use only according to the prescribing information and healthcare professional's advice. Do not exceed the recommended dose.
Possible Side Effects
Possible adverse effects may include:
Tremor
Nervousness
Headache
Dizziness
Palpitations
Increased heart rate
Chest discomfort/pain
The official U.S. label also warns about paradoxical bronchospasm, cardiovascular effects, hypokalemia and changes in blood glucose.
Precautions & Important Safety Information
Patients should inform their healthcare professional about existing medical conditions and medicines they take before using levalbuterol.
Particular caution may be required in patients with:
Cardiovascular disorders
Previous hypersensitivity to levalbuterol or racemic albuterol
Conditions associated with low potassium
Diabetes or blood-glucose concerns
Do not use in patients with known hypersensitivity to levalbuterol, racemic albuterol or relevant formulation components.
Paradoxical bronchospasm can be serious. If breathing becomes worse immediately after inhalation, urgent medical assessment is required and the product should be discontinued as directed by the prescribing information.
Why Choose Cordium Pharmaceuticals?
Cordium Pharmaceuticals Pvt Ltd focuses on international pharmaceutical sourcing and B2B export support from India.
Key Reasons to Choose Cordium Pharmaceuticals
✓ India-based pharmaceutical export partner
✓ B2B supply support for international buyers
✓ Support for hospitals, pharmacies, clinics and distributors
✓ International enquiry and order coordination
✓ Product-focused sourcing and documentation support
✓ Professional communication for overseas buyers
✓ Export-oriented pharmaceutical supply network
✓ Support for destination-market requirements and buyer documentation
Levosalbutamol Inhaler – Export & B2B Supply
Cordium Pharmaceuticals welcomes enquiries from:
Pharmaceutical importers
Wholesalers
Distributors
Hospitals
Clinics
Pharmacies
Respiratory-care suppliers
Healthcare procurement companies
International pharmaceutical trading companies
B2B enquiries are subject to product availability, applicable export regulations, destination-country registration requirements and import permissions.
International Markets We Target
🇺🇸 USA UK 🇬🇧 UAE 🇦🇪 SOUTH 🇿🇦 SINGAPORE 🇸🇬 KENYA 🇰🇪 MALAYSIA 🇲🇾
Contact Cordium Pharmaceuticals
Cordium Pharmaceuticals Pvt Ltd
WhatsApp / Mobile: +91-9405117673
Email: info@cordiumpharma.com
Levosalbutamol (Levalbuterol) Inhaler is a short-acting beta-2 adrenergic bronchodilator used for the treatment or prevention of bronchospasm associated with reversible obstructive airway conditions. It works by relaxing airway smooth muscle and helping improve airflow.
Cordium Pharmaceuticals Pvt Ltd supports B2B pharmaceutical supply and international export enquiries for respiratory medicines, subject to destination-country regulatory requirements and applicable approvals.
Product Specification
Specification
Details
Product Name
Levosalbutamol Inhaler
Generic Name
Levosalbutamol / Levalbuterol
Therapeutic Category
Bronchodilator
Pharmacological Class
Short-acting β2-adrenergic agonist
Dosage Form
Metered-dose inhalation aerosol
Route
Oral inhalation
Main Use
Treatment/prevention of bronchospasm
Target Buyers
Hospitals, Clinics, Pharmacies, Distributors & Importers
Supply Type
B2B / Pharmaceutical Export
Prescription Status
Subject to destination-country regulations
Important: Exact strength, actuation content, pack size and registration status should be confirmed against the specific product presentation and destination market before commercial supply.
Uses of Levosalbutamol Inhaler
Levosalbutamol inhalation products are used for:
Relief/prevention of bronchospasm
Reversible obstructive airway disease
Asthma-related bronchospasm
Bronchodilation under medical supervision
The U.S. prescribing information for levalbuterol inhalation aerosol indicates use for treatment or prevention of bronchospasm in adults, adolescents and children aged 4 years and older with reversible obstructive airway disease.
Mechanism of Action
Levosalbutamol is a selective β2-adrenergic receptor agonist. It stimulates β2 receptors in bronchial smooth muscle, activating intracellular pathways that promote smooth-muscle relaxation. This produces bronchodilation and improved airflow.
Dosage Information
Dosage depends on the specific inhaler strength, age, clinical condition and prescribing information applicable in the destination country.
For the U.S.-labelled levalbuterol HFA inhaler, the recommended dosage for adults and children aged 4 years and older is generally 2 inhalations (90 mcg levalbuterol free base) every 4–6 hours; for some patients, 1 inhalation every 4 hours may be sufficient. More frequent administration or higher doses are not routinely recommended.
Use only according to the prescribing information and healthcare professional's advice. Do not exceed the recommended dose.
Possible Side Effects
Possible adverse effects may include:
Tremor
Nervousness
Headache
Dizziness
Palpitations
Increased heart rate
Chest discomfort/pain
The official U.S. label also warns about paradoxical bronchospasm, cardiovascular effects, hypokalemia and changes in blood glucose.
Precautions & Important Safety Information
Patients should inform their healthcare professional about existing medical conditions and medicines they take before using levalbuterol.
Particular caution may be required in patients with:
Cardiovascular disorders
Previous hypersensitivity to levalbuterol or racemic albuterol
Conditions associated with low potassium
Diabetes or blood-glucose concerns
Do not use in patients with known hypersensitivity to levalbuterol, racemic albuterol or relevant formulation components.
Paradoxical bronchospasm can be serious. If breathing becomes worse immediately after inhalation, urgent medical assessment is required and the product should be discontinued as directed by the prescribing information.
Why Choose Cordium Pharmaceuticals?
Cordium Pharmaceuticals Pvt Ltd focuses on international pharmaceutical sourcing and B2B export support from India.
Key Reasons to Choose Cordium Pharmaceuticals
✓ India-based pharmaceutical export partner
✓ B2B supply support for international buyers
✓ Support for hospitals, pharmacies, clinics and distributors
✓ International enquiry and order coordination
✓ Product-focused sourcing and documentation support
✓ Professional communication for overseas buyers
✓ Export-oriented pharmaceutical supply network
✓ Support for destination-market requirements and buyer documentation
Levosalbutamol Inhaler – Export & B2B Supply
Cordium Pharmaceuticals welcomes enquiries from:
Pharmaceutical importers
Wholesalers
Distributors
Hospitals
Clinics
Pharmacies
Respiratory-care suppliers
Healthcare procurement companies
International pharmaceutical trading companies
B2B enquiries are subject to product availability, applicable export regulations, destination-country registration requirements and import permissions.
International Markets We Target
🇺🇸 USA UK 🇬🇧 UAE 🇦🇪 SOUTH 🇿🇦 SINGAPORE 🇸🇬 KENYA 🇰🇪 MALAYSIA 🇲🇾
Contact Cordium Pharmaceuticals
Cordium Pharmaceuticals Pvt Ltd
WhatsApp / Mobile: +91-9405117673
Email: info@cordiumpharma.com
Keywords
